Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q96P26
UPID:
5NT1B_HUMAN
Alternative names:
Autoimmune infertility-related protein; Cytosolic 5'-nucleotidase IB
Alternative UPACC:
Q96P26; B5MCR0; B7ZVX7; Q53RX2; Q8N9W3; Q8NA26; Q96DU5; Q96KE6; Q96M25; Q96SA3
Background:
Cytosolic 5'-nucleotidase 1B, also known as Autoimmune infertility-related protein, plays a crucial role in cellular metabolism by catalyzing the hydrolysis of nucleotide monophosphates. This process releases inorganic phosphate and the corresponding nucleoside, with AMP being the major substrate. The enzyme's activity is pivotal for maintaining the balance of nucleotides within the cell, which is essential for various biochemical pathways.
Therapeutic significance:
Understanding the role of Cytosolic 5'-nucleotidase 1B could open doors to potential therapeutic strategies. Its fundamental role in nucleotide metabolism makes it a potential target for interventions in diseases where nucleotide balance is disrupted.